Get alerts:The virtual-care technology company said its adjusted EBITDA loss was $1.15 million, compared with a $4.7 million loss in the second quarter of 2025. Amwell’s platform is integrated with MHS GENESIS, the federal health IT platform used by the Military Health System. Company Raises Full-Year EBITDA OutlookFor the third quarter, Amwell forecast revenue of $46 million to $48 million and an adjusted EBITDA loss of $3 million to $5 million. Second-quarter adjusted EBITDA loss: $1.15 million, versus a $4.7 million loss a year earlier. About American Well (NYSE:AMWL)American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients.